Sangamo Therapeutics
$10.989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.23 (-2.04%) Today
-$0.04 (-0.36%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell SGMO and other stocks, options, and ETFs commission-free!
About SGMO
Sangamo Therapeutics, Inc. Common Stock, also called Sangamo Therapeutics, is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.
CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995
Market Cap
1.67B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.14M
High Today
$11.25
Low Today
$10.83
Open Price
$11.25
Volume
894.23K
52 Week High
$19.43
52 Week Low
$6.97
Analyst Ratings
64%
of 11 ratings
Buy
64%
Hold
36%
Sell
0%
SGMO Earnings
-$0.37
-$0.23
-$0.10
$0.04
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours